Clinical Trial Update: fMRI-neuronavigated rTMS for the Treatment of Major Depression Associated With TBI [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating fMRI-neuronavigated repetitive transcranial magnetic stimulation for major depressive disorder associated with traumatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Traumatic Brain Injury

Drugs mentioned

• fMRI-neuronavigated rTMS

Snippet

Sponsor: Washington University School of Medicine | Conditions: Major Depressive Disorder, Traumatic Brain Injury | Phase 2 | Status: TERMINATED